Clover Health Investments (CLOV) Gross Profit (2020 - 2026)
Clover Health Investments posted quarterly Gross Profit of $154.5 million for Q1 2026, up 41.93% year-on-year from $108.9 million in Q1 2025, and up 113.53% on a QoQ basis from $72.4 million in Q4 2025.
Clover Health Investments (CLOV) has 7 years of Gross Profit data on file, last reported at $154.5 million in Q1 2026.
- For the quarter ending Q1 2026, Gross Profit rose 41.93% year-over-year to $154.5 million; the trailing twelve-month figure through Mar 2026 stood at $399.7 million (up 1.99% YoY), and the FY2025 full-year result was $323.3 million, down 11.37% from the prior year.
- Gross Profit for Q1 2026 stood at $154.5 million, up from $72.4 million in the prior quarter.
- Across five years, Gross Profit topped out at $154.5 million in Q1 2026 and bottomed at -$590.3 million in Q2 2022.
- The 5-year median for Gross Profit is $73.2 million (2025), against an average of $1.8 million.
- The widest annual swing landed in 2022, when Gross Profit tumbled 3778.98%; it then jumped 312.76% in 2023.
- A 5-year view of Gross Profit shows it stood at $74.2 million in 2022, then decreased by 15.6% to $62.6 million in 2023, then soared by 49.96% to $93.9 million in 2024, then decreased by 22.94% to $72.4 million in 2025, then surged by 113.53% to $154.5 million in 2026.
- The last three Gross Profit figures came in at $154.5 million (Q1 2026), $72.4 million (Q4 2025), and $73.2 million (Q3 2025), per Business Quant data.